APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rare Disease CRO Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Rare Disease CRO Service Market Analysis and Forecast 2026-2032

1 January 2026206 pages

Choose your research edition.

Industry ResearchRare Disease CRO Service Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Rare Disease CRO Service Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Rare Disease CRO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rare Disease CRO Service Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Rare Disease CRO Service Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Rare Disease CRO Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Rare Disease CRO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Rare Disease CRO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Rare Disease CRO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Rare Disease CRO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Rare Disease CRO Service include Precision for Medicine, Orphan-Reach, Medpace, Parexel, PPD, Worldwide Clinical Trials, AllStripes, LabCorp and Novotech, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Rare Disease CRO Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Rare Disease CRO Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Rare Disease CRO Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Rare Disease CRO Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Rare Disease CRO Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Rare Disease CRO Service revenue, projected growth trends, production technology, application and end-user industry.

Rare Disease CRO Service Segment by Company

Precision for Medicine

Orphan-Reach

Medpace

Parexel

PPD

Worldwide Clinical Trials

AllStripes

LabCorp

Novotech

Syneos Health

Vial

Machaon Diagnostics

Caidya

Simbec Orion

Linical

MMS

Veristat

Celero

Rho

PROMETRIKA

Rare Disease CRO Service Segment by Type

Drug Development Strategy

Clinical Trial Management

Rare Disease CRO Service Segment by Application

Cardiovascular

Neuroscience

Ophthalmology

Others

Rare Disease CRO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rare Disease CRO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rare Disease CRO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rare Disease CRO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Rare Disease CRO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Rare Disease CRO Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Rare Disease CRO Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Rare Disease CRO Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drug Development Strategy Major Player Table 3. Clinical Trial Management Major Player Table 4. Global Rare Disease CRO Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cardiovascular Major Player Table 6. Neuroscience Major Player Table 7. Ophthalmology Major Player Table 8. Others Major Player Table 9. Rare Disease CRO Service Industry Trends Table 10. Rare Disease CRO Service Industry Drivers Table 11. Rare Disease CRO Service Industry Opportunities and Challenges Table 12. Rare Disease CRO Service Industry Restraints Table 13. Global Rare Disease CRO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Rare Disease CRO Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Rare Disease CRO Service Market Share by Region (2021-2026) Table 16. Global Rare Disease CRO Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Rare Disease CRO Service Market Share by Region (2027-2032) Table 18. Global Rare Disease CRO Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Rare Disease CRO Service Revenue Market Share by Players (2021-2026) Table 20. Global Rare Disease CRO Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Rare Disease CRO Service Key Players Headquarters & Area Served Table 22. Global Rare Disease CRO Service Players, Product Type & Application Table 23. Global Rare Disease CRO Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Rare Disease CRO Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Rare Disease CRO Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Rare Disease CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Rare Disease CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Rare Disease CRO Service Revenue Market Share by Type (2021-2026) Table 30. Global Rare Disease CRO Service Revenue Market Share by Type (2027-2032) Table 31. Global Rare Disease CRO Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Rare Disease CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Rare Disease CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Rare Disease CRO Service Revenue Market Share by Application (2021-2026) Table 35. Global Rare Disease CRO Service Revenue Market Share by Application (2027-2032) Table 36. Precision for Medicine Company Information Table 37. Precision for Medicine Business Overview Table 38. Precision for Medicine Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Precision for Medicine Rare Disease CRO Service Product Portfolio Table 40. Precision for Medicine Recent Development Table 41. Orphan-Reach Company Information Table 42. Orphan-Reach Business Overview Table 43. Orphan-Reach Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Orphan-Reach Rare Disease CRO Service Product Portfolio Table 45. Orphan-Reach Recent Development Table 46. Medpace Company Information Table 47. Medpace Business Overview Table 48. Medpace Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Medpace Rare Disease CRO Service Product Portfolio Table 50. Medpace Recent Development Table 51. Parexel Company Information Table 52. Parexel Business Overview Table 53. Parexel Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Parexel Rare Disease CRO Service Product Portfolio Table 55. Parexel Recent Development Table 56. PPD Company Information Table 57. PPD Business Overview Table 58. PPD Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. PPD Rare Disease CRO Service Product Portfolio Table 60. PPD Recent Development Table 61. Worldwide Clinical Trials Company Information Table 62. Worldwide Clinical Trials Business Overview Table 63. Worldwide Clinical Trials Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Worldwide Clinical Trials Rare Disease CRO Service Product Portfolio Table 65. Worldwide Clinical Trials Recent Development Table 66. AllStripes Company Information Table 67. AllStripes Business Overview Table 68. AllStripes Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. AllStripes Rare Disease CRO Service Product Portfolio Table 70. AllStripes Recent Development Table 71. LabCorp Company Information Table 72. LabCorp Business Overview Table 73. LabCorp Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. LabCorp Rare Disease CRO Service Product Portfolio Table 75. LabCorp Recent Development Table 76. Novotech Company Information Table 77. Novotech Business Overview Table 78. Novotech Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Novotech Rare Disease CRO Service Product Portfolio Table 80. Novotech Recent Development Table 81. Syneos Health Company Information Table 82. Syneos Health Business Overview Table 83. Syneos Health Rare Disease CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Syneos Health Rare Disease CRO Service Product Portfolio Table 85. Syneos Health Recent Development Table 86. Vial Company Information Table 87. Vial Business Overview Table 88. Vial Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Vial Rare Disease CRO Service Product Portfolio Table 90. Vial Recent Development Table 91. Machaon Diagnostics Company Information Table 92. Machaon Diagnostics Business Overview Table 93. Machaon Diagnostics Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Machaon Diagnostics Rare Disease CRO Service Product Portfolio Table 95. Machaon Diagnostics Recent Development Table 96. Caidya Company Information Table 97. Caidya Business Overview Table 98. Caidya Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Caidya Rare Disease CRO Service Product Portfolio Table 100. Caidya Recent Development Table 101. Simbec Orion Company Information Table 102. Simbec Orion Business Overview Table 103. Simbec Orion Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Simbec Orion Rare Disease CRO Service Product Portfolio Table 105. Simbec Orion Recent Development Table 106. Linical Company Information Table 107. Linical Business Overview Table 108. Linical Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Linical Rare Disease CRO Service Product Portfolio Table 110. Linical Recent Development Table 111. MMS Company Information Table 112. MMS Business Overview Table 113. MMS Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. MMS Rare Disease CRO Service Product Portfolio Table 115. MMS Recent Development Table 116. Veristat Company Information Table 117. Veristat Business Overview Table 118. Veristat Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Veristat Rare Disease CRO Service Product Portfolio Table 120. Veristat Recent Development Table 121. Celero Company Information Table 122. Celero Business Overview Table 123. Celero Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Celero Rare Disease CRO Service Product Portfolio Table 125. Celero Recent Development Table 126. Rho Company Information Table 127. Rho Business Overview Table 128. Rho Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Rho Rare Disease CRO Service Product Portfolio Table 130. Rho Recent Development Table 131. PROMETRIKA Company Information Table 132. PROMETRIKA Business Overview Table 133. PROMETRIKA Rare Disease CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. PROMETRIKA Rare Disease CRO Service Product Portfolio Table 135. PROMETRIKA Recent Development Table 136. North America Rare Disease CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 137. North America Rare Disease CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 138. North America Rare Disease CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Rare Disease CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Rare Disease CRO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. North America Rare Disease CRO Service Revenue by Country (2021-2026) & (US$ Million) Table 142. North America Rare Disease CRO Service Revenue by Country (US$ Million) & (2027-2032) Table 143. Europe Rare Disease CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 144. Europe Rare Disease CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 145. Europe Rare Disease CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 146. Europe Rare Disease CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 147. Europe Rare Disease CRO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. Europe Rare Disease CRO Service Revenue by Country (2021-2026) & (US$ Million) Table 149. Europe Rare Disease CRO Service Revenue by Country (US$ Million) & (2027-2032) Table 150. China Rare Disease CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 151. China Rare Disease CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 152. China Rare Disease CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 153. China Rare Disease CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Rare Disease CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 155. Asia Rare Disease CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 156. Asia Rare Disease CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Rare Disease CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Rare Disease CRO Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Rare Disease CRO Service Revenue by Region (US$ Million) & (2021-2026) Table 160. Asia Rare Disease CRO Service Revenue by Region (US$ Million) & (2027-2032) Table 161. SAMEA Rare Disease CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 162. SAMEA Rare Disease CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 163. SAMEA Rare Disease CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 164. SAMEA Rare Disease CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 165. SAMEA Rare Disease CRO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA Rare Disease CRO Service Revenue by Country (2021-2026) & (US$ Million) Table 167. SAMEA Rare Disease CRO Service Revenue by Country (US$ Million) & (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Rare Disease CRO Service Image Figure 2. Global Rare Disease CRO Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rare Disease CRO Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drug Development Strategy Image Figure 5. Clinical Trial Management Image Figure 6. Global Rare Disease CRO Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Rare Disease CRO Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cardiovascular Image Figure 9. Neuroscience Image Figure 10. Ophthalmology Image Figure 11. Others Image Figure 12. Global Rare Disease CRO Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Rare Disease CRO Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Rare Disease CRO Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Rare Disease CRO Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Rare Disease CRO Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Rare Disease CRO Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Rare Disease CRO Service Revenue Market Share by Type (2021-2032) Figure 20. Global Rare Disease CRO Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Rare Disease CRO Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Rare Disease CRO Service Revenue Market Share by Application (2021-2032) Figure 23. North America Rare Disease CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Rare Disease CRO Service Revenue Share by Type (2021-2032) Figure 25. North America Rare Disease CRO Service Revenue Share by Application (2021-2032) Figure 26. North America Rare Disease CRO Service Revenue Share by Country (2021-2032) Figure 27. United States Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Rare Disease CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Rare Disease CRO Service Revenue Share by Type (2021-2032) Figure 32. Europe Rare Disease CRO Service Revenue Share by Application (2021-2032) Figure 33. Europe Rare Disease CRO Service Revenue Share by Country (2021-2032) Figure 34. Germany Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Rare Disease CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Rare Disease CRO Service Revenue Share by Type (2021-2032) Figure 44. China Rare Disease CRO Service Revenue Share by Application (2021-2032) Figure 45. Asia Rare Disease CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Rare Disease CRO Service Revenue Share by Type (2021-2032) Figure 47. Asia Rare Disease CRO Service Revenue Share by Application (2021-2032) Figure 48. Asia Rare Disease CRO Service Revenue Share by Region (2021-2032) Figure 49. Japan Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Rare Disease CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Rare Disease CRO Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Rare Disease CRO Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Rare Disease CRO Service Revenue Share by Country (2021-2032) Figure 59. Brazil Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Rare Disease CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Development Strategy
  • Clinical Trial Management
Applications
  • Cardiovascular
  • Neuroscience
  • Ophthalmology
  • Others
Companies covered
  • Precision for Medicine
  • Orphan-Reach
  • Medpace
  • Parexel
  • PPD
  • Worldwide Clinical Trials
  • AllStripes
  • LabCorp
  • Novotech
  • Syneos Health
  • Vial
  • Machaon Diagnostics
  • Caidya
  • Simbec Orion
  • Linical
  • MMS
  • Veristat
  • Celero
  • Rho
  • PROMETRIKA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Rare Disease CRO Service Market by Type
  3. 1.2.1 Global Rare Disease CRO Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drug Development Strategy
  5. 1.2.3 Clinical Trial Management
  6. 1.3 Rare Disease CRO Service Market by Application
  7. 1.3.1 Global Rare Disease CRO Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cardiovascular
  9. 1.3.3 Neuroscience
  10. 1.3.4 Ophthalmology
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Rare Disease CRO Service Market Dynamics
  1. 2.1 Rare Disease CRO Service Industry Trends
  2. 2.2 Rare Disease CRO Service Industry Drivers
  3. 2.3 Rare Disease CRO Service Industry Opportunities and Challenges
  4. 2.4 Rare Disease CRO Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Rare Disease CRO Service Market Perspective (2021-2032)
  2. 3.2 Global Rare Disease CRO Service Growth Trends by Region
  3. 3.2.1 Global Rare Disease CRO Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Rare Disease CRO Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Rare Disease CRO Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Rare Disease CRO Service Revenue by Players
  2. 4.1.1 Global Rare Disease CRO Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Rare Disease CRO Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Rare Disease CRO Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Rare Disease CRO Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Rare Disease CRO Service Key Players Headquarters & Area Served
  7. 4.4 Global Rare Disease CRO Service Players, Product Type & Application
  8. 4.5 Global Rare Disease CRO Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Rare Disease CRO Service Market CR5 and HHI
  11. 4.6.3 2025 Rare Disease CRO Service Tier 1, Tier 2, and Tier 3
5 Rare Disease CRO Service Market Size by Type
  1. 5.1 Global Rare Disease CRO Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Rare Disease CRO Service Revenue by Type (2021-2032)
  3. 5.3 Global Rare Disease CRO Service Revenue Market Share by Type (2021-2032)
6 Rare Disease CRO Service Market Size by Application
  1. 6.1 Global Rare Disease CRO Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Rare Disease CRO Service Revenue by Application (2021-2032)
  3. 6.3 Global Rare Disease CRO Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Precision for Medicine
  2. 7.1.1 Precision for Medicine Company Information
  3. 7.1.2 Precision for Medicine Business Overview
  4. 7.1.3 Precision for Medicine Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Precision for Medicine Rare Disease CRO Service Product Portfolio
  6. 7.1.5 Precision for Medicine Recent Developments
  7. 7.2 Orphan-Reach
  8. 7.2.1 Orphan-Reach Company Information
  9. 7.2.2 Orphan-Reach Business Overview
  10. 7.2.3 Orphan-Reach Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Orphan-Reach Rare Disease CRO Service Product Portfolio
  12. 7.2.5 Orphan-Reach Recent Developments
  13. 7.3 Medpace
  14. 7.3.1 Medpace Company Information
  15. 7.3.2 Medpace Business Overview
  16. 7.3.3 Medpace Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Medpace Rare Disease CRO Service Product Portfolio
  18. 7.3.5 Medpace Recent Developments
  19. 7.4 Parexel
  20. 7.4.1 Parexel Company Information
  21. 7.4.2 Parexel Business Overview
  22. 7.4.3 Parexel Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Parexel Rare Disease CRO Service Product Portfolio
  24. 7.4.5 Parexel Recent Developments
  25. 7.5 PPD
  26. 7.5.1 PPD Company Information
  27. 7.5.2 PPD Business Overview
  28. 7.5.3 PPD Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PPD Rare Disease CRO Service Product Portfolio
  30. 7.5.5 PPD Recent Developments
  31. 7.6 Worldwide Clinical Trials
  32. 7.6.1 Worldwide Clinical Trials Company Information
  33. 7.6.2 Worldwide Clinical Trials Business Overview
  34. 7.6.3 Worldwide Clinical Trials Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Worldwide Clinical Trials Rare Disease CRO Service Product Portfolio
  36. 7.6.5 Worldwide Clinical Trials Recent Developments
  37. 7.7 AllStripes
  38. 7.7.1 AllStripes Company Information
  39. 7.7.2 AllStripes Business Overview
  40. 7.7.3 AllStripes Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 AllStripes Rare Disease CRO Service Product Portfolio
  42. 7.7.5 AllStripes Recent Developments
  43. 7.8 LabCorp
  44. 7.8.1 LabCorp Company Information
  45. 7.8.2 LabCorp Business Overview
  46. 7.8.3 LabCorp Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 LabCorp Rare Disease CRO Service Product Portfolio
  48. 7.8.5 LabCorp Recent Developments
  49. 7.9 Novotech
  50. 7.9.1 Novotech Company Information
  51. 7.9.2 Novotech Business Overview
  52. 7.9.3 Novotech Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Novotech Rare Disease CRO Service Product Portfolio
  54. 7.9.5 Novotech Recent Developments
  55. 7.10 Syneos Health
  56. 7.10.1 Syneos Health Company Information
  57. 7.10.2 Syneos Health Business Overview
  58. 7.10.3 Syneos Health Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Syneos Health Rare Disease CRO Service Product Portfolio
  60. 7.10.5 Syneos Health Recent Developments
  61. 7.11 Vial
  62. 7.11.1 Vial Company Information
  63. 7.11.2 Vial Business Overview
  64. 7.11.3 Vial Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Vial Rare Disease CRO Service Product Portfolio
  66. 7.11.5 Vial Recent Developments
  67. 7.12 Machaon Diagnostics
  68. 7.12.1 Machaon Diagnostics Company Information
  69. 7.12.2 Machaon Diagnostics Business Overview
  70. 7.12.3 Machaon Diagnostics Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Machaon Diagnostics Rare Disease CRO Service Product Portfolio
  72. 7.12.5 Machaon Diagnostics Recent Developments
  73. 7.13 Caidya
  74. 7.13.1 Caidya Company Information
  75. 7.13.2 Caidya Business Overview
  76. 7.13.3 Caidya Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Caidya Rare Disease CRO Service Product Portfolio
  78. 7.13.5 Caidya Recent Developments
  79. 7.14 Simbec Orion
  80. 7.14.1 Simbec Orion Company Information
  81. 7.14.2 Simbec Orion Business Overview
  82. 7.14.3 Simbec Orion Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Simbec Orion Rare Disease CRO Service Product Portfolio
  84. 7.14.5 Simbec Orion Recent Developments
  85. 7.15 Linical
  86. 7.15.1 Linical Company Information
  87. 7.15.2 Linical Business Overview
  88. 7.15.3 Linical Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Linical Rare Disease CRO Service Product Portfolio
  90. 7.15.5 Linical Recent Developments
  91. 7.16 MMS
  92. 7.16.1 MMS Company Information
  93. 7.16.2 MMS Business Overview
  94. 7.16.3 MMS Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  95. 7.16.4 MMS Rare Disease CRO Service Product Portfolio
  96. 7.16.5 MMS Recent Developments
  97. 7.17 Veristat
  98. 7.17.1 Veristat Company Information
  99. 7.17.2 Veristat Business Overview
  100. 7.17.3 Veristat Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Veristat Rare Disease CRO Service Product Portfolio
  102. 7.17.5 Veristat Recent Developments
  103. 7.18 Celero
  104. 7.18.1 Celero Company Information
  105. 7.18.2 Celero Business Overview
  106. 7.18.3 Celero Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Celero Rare Disease CRO Service Product Portfolio
  108. 7.18.5 Celero Recent Developments
  109. 7.19 Rho
  110. 7.19.1 Rho Company Information
  111. 7.19.2 Rho Business Overview
  112. 7.19.3 Rho Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Rho Rare Disease CRO Service Product Portfolio
  114. 7.19.5 Rho Recent Developments
  115. 7.20 PROMETRIKA
  116. 7.20.1 PROMETRIKA Company Information
  117. 7.20.2 PROMETRIKA Business Overview
  118. 7.20.3 PROMETRIKA Rare Disease CRO Service Revenue and Gross Margin (2021-2026)
  119. 7.20.4 PROMETRIKA Rare Disease CRO Service Product Portfolio
  120. 7.20.5 PROMETRIKA Recent Developments
8 North America
  1. 8.1 North America Rare Disease CRO Service Revenue (2021-2032)
  2. 8.2 North America Rare Disease CRO Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Rare Disease CRO Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Rare Disease CRO Service Revenue by Type (2027-2032)
  5. 8.3 North America Rare Disease CRO Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Rare Disease CRO Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Rare Disease CRO Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Rare Disease CRO Service Revenue by Application (2027-2032)
  9. 8.5 North America Rare Disease CRO Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Rare Disease CRO Service Revenue by Country
  11. 8.6.1 North America Rare Disease CRO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Rare Disease CRO Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Rare Disease CRO Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Rare Disease CRO Service Revenue (2021-2032)
  2. 9.2 Europe Rare Disease CRO Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Rare Disease CRO Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Rare Disease CRO Service Revenue by Type (2027-2032)
  5. 9.3 Europe Rare Disease CRO Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Rare Disease CRO Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Rare Disease CRO Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Rare Disease CRO Service Revenue by Application (2027-2032)
  9. 9.5 Europe Rare Disease CRO Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Rare Disease CRO Service Revenue by Country
  11. 9.6.1 Europe Rare Disease CRO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Rare Disease CRO Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Rare Disease CRO Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Rare Disease CRO Service Revenue (2021-2032)
  2. 10.2 China Rare Disease CRO Service Revenue by Type (2021-2032)
  3. 10.2.1 China Rare Disease CRO Service Revenue by Type (2021-2026)
  4. 10.2.2 China Rare Disease CRO Service Revenue by Type (2027-2032)
  5. 10.3 China Rare Disease CRO Service Revenue Share by Type (2021-2032)
  6. 10.4 China Rare Disease CRO Service Revenue by Application (2021-2032)
  7. 10.4.1 China Rare Disease CRO Service Revenue by Application (2021-2026)
  8. 10.4.2 China Rare Disease CRO Service Revenue by Application (2027-2032)
  9. 10.5 China Rare Disease CRO Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Rare Disease CRO Service Revenue (2021-2032)
  2. 11.2 Asia Rare Disease CRO Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Rare Disease CRO Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Rare Disease CRO Service Revenue by Type (2027-2032)
  5. 11.3 Asia Rare Disease CRO Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Rare Disease CRO Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Rare Disease CRO Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Rare Disease CRO Service Revenue by Application (2027-2032)
  9. 11.5 Asia Rare Disease CRO Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Rare Disease CRO Service Revenue by Country
  11. 11.6.1 Asia Rare Disease CRO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Rare Disease CRO Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Rare Disease CRO Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Rare Disease CRO Service Revenue (2021-2032)
  2. 12.2 SAMEA Rare Disease CRO Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Rare Disease CRO Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Rare Disease CRO Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Rare Disease CRO Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Rare Disease CRO Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Rare Disease CRO Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Rare Disease CRO Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Rare Disease CRO Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Rare Disease CRO Service Revenue by Country
  11. 12.6.1 SAMEA Rare Disease CRO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Rare Disease CRO Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Rare Disease CRO Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst